Sun Tao, Chen Mingqi, Lin Xiaoyan, Yu Ruixiang, Zhao Yong, Wang Jianhang
Yantaishan Hospital, Yantai 264000, Shangdong Province, People's Republic of China.
Yantai Zhifu Hospital, Yantai 264000, Shangdong Province, People's Republic of China.
Int Immunopharmacol. 2014 Sep;22(1):200-3. doi: 10.1016/j.intimp.2014.06.023. Epub 2014 Jun 24.
Previous studies suggest that the osteoprotegerin gene (OPG) plays an important role in the development of osteoporosis. This study aims to investigate the potential association between OPG genetic polymorphisms and bone mineral density (BMD) and osteoporosis in postmenopausal women. 938 Chinese postmenopausal women were enrolled. The lumbar spine (L(2-4)) BMD, neck BMD, and total hip BMD were measured by dual energy X-ray absorptiometry (DEXA). The genotypes of OPG genetic polymorphisms were evaluated by the created restriction site-polymerase chain reaction (CRS-PCR), PCR-restriction fragment length polymorphism (PCR-RFLP), and DNA sequencing methods. Our data indicated that subjects with genotype TT of the g.26395T>C genetic polymorphism showed a significantly higher adjusted value of BMD when compared with those of genotypes TC and CC. Subjects with genotype AA of the g.27649A>G genetic polymorphism showed a significantly higher adjusted value of BMD than those of genotypes AG and GG. These findings suggest that the OPG genetic polymorphisms may affect BMD and osteoporosis in Chinese postmenopausal women.
以往研究表明,骨保护素基因(OPG)在骨质疏松症的发生发展中起重要作用。本研究旨在探讨OPG基因多态性与绝经后女性骨密度(BMD)及骨质疏松症之间的潜在关联。纳入了938名中国绝经后女性。采用双能X线吸收法(DEXA)测量腰椎(L(2-4))骨密度、颈部骨密度和全髋骨密度。通过创建限制性位点-聚合酶链反应(CRS-PCR)、PCR-限制性片段长度多态性(PCR-RFLP)和DNA测序方法评估OPG基因多态性的基因型。我们的数据表明,g.26395T>C基因多态性的TT基因型受试者与TC和CC基因型受试者相比,调整后的骨密度值显著更高。g.27649A>G基因多态性的AA基因型受试者比AG和GG基因型受试者的调整后骨密度值显著更高。这些发现表明,OPG基因多态性可能影响中国绝经后女性的骨密度和骨质疏松症。